Delivery Order SPE2DB20D1100-SPE2DB25FE4W8
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100 count) valued at $2,856.60. This non-competitive, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Methylphenidate ER 36 mg tablets (100 count) with a ceiling value of $2,544.82. This is a firm fixed-price delivery order with no set-aside designation, executed competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order valued at $1,128.17 to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100-count supply) on June 9, 2025, with completion scheduled for June 10, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for methylphenidate ER 36mg tablets (100-count) with a ceiling value of $5,179.68. This non-competitive, firm fixed-price delivery order was issued on September 12, 2025, with an ultimate completion date of the same day. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count packages) with a contract value of $2,196.52. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively determined. The order is scheduled for completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,448.52 to supply Methylphenidate ER 36 mg tablets (100-count units) with an ultimate completion date of August 19, 2025. The contract is classified as a non-set-aside, competitively awarded delivery order with firm fixed pricing. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,043.04 to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100 count) on July 22, 2025, with a completion date of July 23, 2025. This non-set-aside, firm fixed price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count) with a ceiling value of $4,009.26. The contract, awarded on September 16, 2025, utilizes firm fixed-price pricing with an ultimate completion date of September 17, 2025. This non-competitive, non-set-aside delivery order was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $1,296.30 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100-count bottles) with an ultimate completion date of July 1, 2025. This is a firm fixed-price, non-set-aside contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026. The product will be delivered to AmerisourceBergen's facility...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100 count) valued at $4,175.73 on August 11, 2025, with completion targeted for August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The products will be performed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE4W8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $8,438.26, was competitively awarded without a set-aside designation and is scheduled for completion by September 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the Defense Logistics Agency's medical supply chain operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026. This comprehensive contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs and other federal health systems worldwide. AmerisourceBergen's extensive portfolio of federal medical contracts demonstrates its established capability to meet competitive procurement requirements across multiple therapeutic domains, including neurological, pain management, and specialty medication categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 9/5/25 |